Skip to main content
NUTX
NASDAQ Trade & Services

Nutex Q3 Profit Falls to $40.2M as Hospital Revenue Drops 19.7%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$193.64
Mkt Cap
$1.326B
52W Low
$83.99
52W High
$226.158
52W Position info
131% above low
Off High info
14% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NUTX has more than doubled off its 52-week low of $83.99.

Summary

Nutex reported Q3 2026 net income of $40.2M ($5.71 diluted) on revenue of $217.6M, down from $55.4M and $267.8M a year earlier, while nine-month earnings were lifted by a $52.3M one-time cut in arbitration-related contract services expense.


Key Events · Earnings and Guidance · NUTX

  • Q3 Profit and Revenue Both Decline

    Net income attributable to Nutex Health was $40.2M, or $5.71 per diluted share, versus $55.4M and $7.76 a year earlier. Total revenue fell to $217.6M from $267.8M.

  • Hospital Division Revenue Down 19.7%

    Hospital division revenue was $209.1M versus $260.2M, a $51.1M decline, which management ties to 2025 catch-up collection data and ineligible-chart reconciliation rather than volume; patient visits rose 18.1%.

  • One-Time $52.3M Arbitration Cost Cut

    The HaloMD pay-on-collected amendment and the CMS IDR administrative fee cut from $115 to $15 reduced nine-month contract services expense by $52.3M, adding $25.0M to net income attributable to Nutex Health ($4.83 per diluted share).

  • Cash Rises to $249.9M

    Cash and equivalents were $249.9M at September 30, 2026 versus $185.6M at December 31, 2025, after $50.7M of repurchases and earn-out settlements and $52.0M of net distributions to noncontrolling interests.


Analysis · NUTX · Trade & Services

The quarter deteriorated meaningfully from the prior year: revenue fell to $217.6M from $267.8M, and net income attributable to Nutex dropped to $40.2M ($5.71 diluted) from $55.4M ($7.76). Management attributes the revenue decline to 2025 having benefited from catch-up collection data and the reconciliation of ineligible charts, not to a collapse in volume — patient visits actually rose 18.1%. The nine-month picture looks far better only because of a one-time $52.3M reduction in contract services expense from the HaloMD pay-on-collected amendment and the CMS IDR fee cut from $115 to $15, which added $25.0M to net income attributable to Nutex. Strip that out and the underlying earnings trend is down, which is what matters for a company whose valuation rests on out-of-network arbitration economics.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NUTX was trading at $193.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $83.99 to $226.16. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUTX - Latest Insights

NUTX
Nov 17, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $169.87
Real-time Price: $162.10 info
Change: -$7.77 (-5%) info
Market Cap: $1.112B info
NUTX
Nov 05, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $193.64
Real-time Price: $162.10 info
Change: -$31.54 (-16%) info
Market Cap: $1.112B info
NUTX
Sep 10, 2026, 5:53 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $195.20
Real-time Price: $162.10 info
Change: -$33.10 (-17%) info
Market Cap: $1.112B info
NUTX
Aug 31, 2026, 4:33 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $188.76
Real-time Price: $162.10 info
Change: -$26.66 (-14%) info
Market Cap: $1.112B info
NUTX
Aug 31, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $188.76
Real-time Price: $162.10 info
Change: -$26.66 (-14%) info
Market Cap: $1.112B info